Levosalbutamol
- Generic Name
- Levosalbutamol
- Brand Names
- Xopenex
- Drug Type
- Small Molecule
- Chemical Formula
- C13H21NO3
- CAS Number
- 34391-04-3
- Unique Ingredient Identifier
- EDN2NBH5SS
- Background
Levosalbutamol, or levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
...
- Indication
Indicated for the management of COPD (chronic obstructive pulmonary disease, also known as chronic obstructive lung disease) and asthma.
- Associated Conditions
- Bronchospasm
- Associated Therapies
- -
Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift
FDA expands DUPIXENT use for COPD, offering new treatment options for patients. COPD affects 44 million in 7MM, with cases expected to rise. DUPIXENT targets IL-4 and IL-13 pathways, reducing exacerbations and improving lung function.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath